World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
36335
World Ranking
17810
National Ranking
8883

Overview

Donna Przepiorka is affiliated with the US Food and Drug Administration in the United States and has contributed extensively to the field of medicine, with a focus on hematology and oncology.

Their research spans several key subfields including hematology, oncology, public health, environmental and occupational health, pediatrics, perinatology and child health, and genetics. The main topics of their work cover:

  • Acute Myeloid Leukemia Research
  • CAR-T cell therapy research
  • Acute Lymphoblastic Leukemia research
  • Hematopoietic Stem Cell Transplantation
  • Chronic Myeloid Leukemia Treatments
  • Renal Transplantation Outcomes and Treatments
  • Childhood Cancer Survivors' Quality of Life

Donna Przepiorka has published regularly in several scientific venues, with the highest number of publications appearing in:

  • Clinical Cancer Research (6 publications)
  • The Oncologist (2 publications)
  • Blood (2 publications)
  • JAMA (2 publications)
  • Blood Advances (1 publication)

Frequently collaborating with other researchers, their most commonly listed co-authors include:

  • R. Angelo de Claro (8 papers)
  • Marc R. Theoret (7 papers)
  • Richard Pazdur (6 papers)
  • Jonathon Vallejo (5 papers)
  • Robert Q. Le (4 papers)

Recent notable publications by Donna Przepiorka include:

  • FDA Approval Summary: Belumosudil for Adult and Pediatric Patients 12 Years and Older with Chronic GvHD after Two or More Prior Lines of Systemic Therapy, 2022, Clinical Cancer Research
  • FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation, 2021, Clinical Cancer Research
  • Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis, 2020, Clinical Cancer Research
  • FDA Approval Summary: Brexucabtagene Autoleucel for Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia, 2022, The Oncologist
  • FDA Approval Summary: Ruxolitinib for Treatment of Chronic Graft-Versus-Host Disease after Failure of One or Two Lines of Systemic Therapy, 2022, The Oncologist

Donna Przepiorka's research is primarily centered on treatments and approvals related to various forms of leukemia and graft-versus-host disease, reflecting a strong focus on clinical advancements within oncology and hematology.

Best Publications

  • 1994 Consensus Conference on Acute GVHD Grading.

    Przepiorka D;Weisdorf D;Martin P;Klingemann Hg

  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

    Madan H. Jagasia;Hildegard T. Greinix;Mukta Arora;Kirsten M. Williams

  • Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

    Sergio Giralt;Elihu Estey;Maher Albitar;Koen Van Besien

  • Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

    I F Khouri;M Keating;M Körbling;D Przepiorka

  • Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

    Sergio Giralt;Peter F. Thall;Issa Khouri;Xuemei Wang

  • IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE

    Rowlings Pa;Przepiorka D;Klein Jp;Gale Rp

  • Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors.

    Richard A. Nash;Joseph H. Antin;Chatchada Karanes;Joseph W. Fay

  • FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome

    Robert Q. Le;Liang Li;Weishi Yuan;Stacy S. Shord

  • Phase III Study Comparing Methotrexate and Tacrolimus (Prograf, FK506) With Methotrexate and Cyclosporine for Graft-Versus-Host Disease Prophylaxis After HLA-Identical Sibling Bone Marrow Transplantation

    Voravit Ratanatharathorn;Richard A. Nash;Donna Przepiorka;Steven M. Devine

  • Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report

    Stephanie J. Lee;Daniel Wolff;Carrie Kitko;John Koreth

  • Allogeneic Blood Stem Cell Transplantation for Refractory Leukemia and Lymphoma: Potential Advantage of Blood Over Marrow Allografts

    M Korbling;D Przepiorka;YO Huh;H Engel

  • CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation

    S. Giralt;J. Hester;Yang O Huh;Cheryl F Hirsch-Ginsberg

  • Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.

    I F Khouri;J Romaguera;H Kantarjian;J L Palmer

  • Community Respiratory Virus Infections Among Hospitalized Adult Bone Marrow Transplant Recipients

    Estella Whimbey;Richard E. Champlin;Robert B. Couch;Janet A. Englund

  • Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

    Stephanie J. Lee;Daniel Wolff;Carrie Kitko;John Koreth

  • Allogeneic Stem Cell Transplantation for Agnogenic Myeloid Metaplasia: A European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study

    P. Guardiola;J. Anderson;G. Bandini;F. Cervantes

  • Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.

    Martin Korbling;Yang O Huh;A. Durett;N. Mirza

  • Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

    D. Przepiorka;N. A. Kernan;C. Ippoliti;E. B. Papadopoulos

  • FDA Approval: Blinatumomab.

    Donna Przepiorka;Chia-Wen Ko;Albert Deisseroth;Carolyn L. Yancey

  • Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals

    Paolo Anderlini;Donna Przepiorka;Richard Champlin;Martin Körbling

Frequent Co-Authors

Richard E. Champlin
Richard E. Champlin The University of Texas MD Anderson Cancer Center
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Issa F. Khouri
Issa F. Khouri The University of Texas MD Anderson Cancer Center
Borje S. Andersson
Borje S. Andersson The University of Texas MD Anderson Cancer Center
Albert B. Deisseroth
Albert B. Deisseroth US Food and Drug Administration
Karen R. Cleary
Karen R. Cleary The University of Texas MD Anderson Cancer Center
John R. Wingard
John R. Wingard University of Florida
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Paul J. Martin
Paul J. Martin Fred Hutchinson Cancer Research Center
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in the healthcare field, but looking for flexible options or alternative career paths beyond traditional medical school? The rise of accredited online programs has opened new doors for those hoping to enter or advance within the industry without relocating or taking on significant debt.

For individuals seeking administrative roles, cheapest medical billing and coding online courses offer an affordable entry point into healthcare by teaching essential skills in medical record management and insurance processing.

For aspiring nurses, there are many cheapest online nursing programs that provide foundational training, often paving the way to licensure and clinical practice. Those who want a more advanced role can explore the most affordable online nurse practitioner programs, which prepare graduates for greater responsibility and independence in patient care.

If you’re already a nursing professional aiming to pursue research or leadership positions, accredited phd nursing programs are available fully online, often with flexible schedules. These programs enable you to contribute to medical science and higher education at the doctoral level.

Best Scientists Citing Donna Przepiorka

Trending Scientists

Recently Published Articles